Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
FANCF
REST API REST API
Homo sapiens
FANCF is differentially expressed in 260 experiments: 92 organism parts: bone marrow, ovary, ... (90 more);, 156 disease states: normal, acute promyelocytic leukemia, ... (154 more);, 77 cell types 372 cell lines 44 compound treatments and 66 other conditions.
Synonyms FAF
Orthologs Q0V8B4_BOVIN (Bos taurus)   FANCF (Gallus gallus)   fancf (Danio rerio)   F1M0R6_RAT (Rattus norvegicus)   Fancf (Mus musculus)   fancf (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term protein binding, DNA repair, biological_process, molecular_function, nucleus, nucleoplasm, Fanconi anaemia nuclear complex
UniProt Accession Q9NPI8, A3KME0
Gene-Disease Assocation FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF, FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
Search EB-eye ENSG00000183161
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-GEOD-803, E-MEXP-1251, E-GEOD-1577, ... (22 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-3860, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, ... (38 experiments)

Factor Value U/D Experiments
BT474
3
E-MTAB-37, E-MTAB-62, E-MEXP-440
MCF-7
3
E-GEOD-20081, E-GEOD-5823, E-GEOD-3529
PC3
3
E-GEOD-5258, E-GEOD-14464, E-MEXP-2034
BT-474
2
E-GEOD-5823, E-GEOD-3529
MOLT4
2
E-MTAB-37, E-MTAB-62
MDA-MB-231
1
2
E-GEOD-5823, E-MTAB-62, E-TABM-420
366 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-21668, E-GEOD-3920, E-GEOD-4219, E-GEOD-20677, ... (42 experiments)

Factor Value U/D Experiments
mononuclear
2
E-GEOD-13987, E-GEOD-26672
partially reprogrammed human induced pluripotent stem cell
2
E-GEOD-18147, E-GEOD-18265
fibroblast
2
E-GEOD-3920, E-GEOD-3204
stromal cell
2
E-GEOD-10797, E-MEXP-2034
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
mononuclear cell
1
E-GEOD-6053
71 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1577, E-MEXP-1121, E-TABM-15, ... (54 experiments)

Factor Value U/D Experiments
control
3
E-GEOD-21912, E-GEOD-8121, E-GEOD-16363
embryonal rhabdomyosarcoma
2
E-MTAB-62, E-MEXP-121
acute lymphoblastic leukemia
2
E-MTAB-37, E-MTAB-62
prostate carcinoma
2
E-MTAB-62, E-MEXP-2034
acute promyelocytic leukemia
1
2
E-MTAB-62, E-GEOD-995, E-GEOD-1729
cervical carcinoma
1
2
E-MTAB-62, E-MTAB-37, E-MEXP-1331
150 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-7400, E-TABM-782, E-GEOD-3720, E-GEOD-5824, ... (26 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-TABM-868, E-MEXP-1958
unknown
1
E-GEOD-7307
glutamine
1
E-MEXP-1335
oligomycin
1
E-MEXP-2285
heregulin
1
E-GEOD-6462
valproic acid
1
E-GEOD-1615
38 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125, E-GEOD-1729

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-MEXP-1251, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22148

Environmental stress
studied in E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-7578, E-GEOD-20847, E-GEOD-4006, ... (6 experiments)

Genotype
studied in E-TABM-763, E-TABM-1029, E-GEOD-17476, E-GEOD-22593, E-TABM-321, ... (11 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-7011, E-TABM-127, E-GEOD-22278, ... (8 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-16194, E-TABM-276

Individual
studied in E-GEOD-5764, E-MEXP-2069, E-TABM-26, E-GEOD-16363, E-GEOD-20876, ... (25 experiments)

individual id
studied in E-GEOD-19519

Infection
studied in E-MEXP-1274, E-GEOD-12254, E-GEOD-17400, E-GEOD-6802

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-21750, E-GEOD-1657, E-GEOD-17636, E-MEXP-1403 ... (5 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-21837, E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-18995

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Stimulus or stress
studied in E-GEOD-7538

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815 ... (5 experiments)

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561

Tumor size
studied in E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.41 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM